Back to Search VC Home Page
Venture Capital Search Engine
search over 1,000 Venture Capital related sites
Keywords about VC:  

Posco Bioventures Inc

1.Acorda :: Current Investors   (66%):
Acorda Therapeutics is a privately held biotechnology company devoted to developing therapies for individuals with spinal cord injury, multiple sclerosis, and related disorders of the nervous system. Since its inception in 1995, Acorda has raised over $140 million through a combination of individua...
2.Anthem Capital Management   (61%):
News | Current News Back to News Nucleonics Raises $49.2 Million Series B Round June 20, 2004 Dow Jones & Company MALVERN, PA - Nucleonics Inc., a biotech start-up developing novel RNA interference-based, or RNAi, therapies, announced that it has raised $49.2 million in Series B financing. The ...
3.Abingworth - Portfolio Companies   (45%):
Portfolio Companies Abingworth Bioventures IIa ABVIIa is an annex fund to ABVII Abingworth Bioventures IV Abingworth Bioventures III Abingworth Bioventures IIa Abingworth Bioventures II Abingworth Bioventures Biotechnology Venture Fund
4.BioAdvance Ventures   (41%):
BioAdvance Ventures is an innovative new venture fund formed to invest in seed and early stage life science companies, located primarily in Southeastern Pennsylvania. The fund is sponsored by BioAdvance, the Biotechnology Greenhouse Corporation of Southeastern Pennsylvania and is managed by Quaker B...
5.BioAdvance Ventures   (41%):
BioAdvance Ventures is an innovative new venture fund formed to invest in seed and early stage life science companies, located primarily in Southeastern Pennsylvania. The fund is sponsored by BioAdvance, the Biotechnology Greenhouse Corporation of Southeastern Pennsylvania and is managed by Quaker B...
6.GreenHills Ventures   (40%):
Investors: Login | Businesses: Submit Plan GreenHills Ventures, LLC., combines extensive advisory experience with strategic initiatives. We focus on providing strong fundamentals to facilitate sound business execution. GreenHills Ventures, LLC., has developed an extensive network of Fortune 1000 co...
7.BioAdvance Ventures : News : Press Releases : September 23, 2004   (34%):
News BioAdvance Ventures Announces Closing of $26 Million Early Stage Life Sciences Fund BioAdvance and Quaker BioVentures Partner to Attract More National Life Sciences Investment to Philadelphia Region Philadelphia and Wayne, PA - September 23, 2004 - BioAdvance, the Biotechnology Greenhouse of So...
8.BioAdvance, The Biotechnology Greenhouse of Southeastern Pennsylvania   (28%):
BioAdvance Ventures is an innovative new venture fund formed to invest in seed and early stage life science companies, located primarily in Southeastern Pennsylvania. The fund is sponsored by BioAdvance, and will be managed by Quaker BioVentures Inc., ( www.quakerbio.com ). The Fund s goal is to pr...
9.Hamilton BioVentures   (27%):
David E. Coats Managing Director David Coats, Managing Director, leads the Life Science team at Hamilton BioVentures. He currently sits on the Boards of PhotoThera, Transoral, and Angstrom Pharmaceuticals, and observes on the Board of Converge Medical. David has over fifteen years experience in the ...
10.Abingworth - Portfolio Companies   (25%):
Portfolio Companies Biotechnology Venture Fund Alkermes (Cambridge, Mass.) is focused on developing proprietary systems to enable drugs across the blood-brain barrier, for the oral delivery of proteins and for sustained release and pulmonary drug delivery. Alkermes went public in July 1991. (08/87) ...
11.BioAdvance Ventures : News : Press Releases : November 22, 2004   (25%):
News Transport Pharmaceuticals Secures $27 Million in Venture Financing to Continue Development of Unique Drug Delivery Platform Carlyle Venture Partners and Quaker BioVentures co-lead Series D funding; Company's innovative oral herpes treatment ready for Phase III clinical trials Framingham, MA and...
12.BioAdvance Ventures : News : Press Releases : December 13, 2004   (25%):
News Neotropix Attracts $10 Million Series A Round For Development of Novel Virotherapies to Treat Cancer MALVERN, Pa.--(BUSINESS WIRE)--Dec. 13, 2004-- VIMAC Milestone Medica, Quaker BioVentures, and The Aurora Funds Co-lead Investment in Pennsylvania-based Company Neotropix(TM), Inc., a company de...
13.BioAdvance Ventures : About Us   (24%):
About Us BioAdvance Ventures is an innovative new venture fund formed to invest in seed and early stage life science companies, located primarily in Southeastern Pennsylvania. The fund is sponsored by BioAdvance, the Biotechnology Greenhouse Corporation of Southeastern Pennsylvania and is managed by...
14.Easton Capital Investment Group::Renovis, Inc.   (24%):
Renovis, Inc. Renovis (NASD:RNVS) is a biopharmaceutical company that discovers and develops drugs to address neurological conditions and neuroinflammatory disorders. The Company has several drug candidates in development, including Cerovive, a Phase III drug for acute ischemic stroke that is partne...
15.GBS Venture Partners :: News and Events   (23%):
NEWS Sunshine Heart Quarterly In... Pharmaxis Ltd Announces Glo... CogState Announces Restruct... CogState Signs Agreement to... Enrolment Commenced in Arid... Novasys Medical Announces N... ASX Announcement - Clinica... Bronchitol Cystic Fibrosis ... Cortical Pty Ltd Presents M... CogState Signs Ag...
16.BioAdvance Ventures : Team   (23%):
Ira M. Lubert | Brenda D. Gavin | P. Sherrill Neff | Richard Kollender | Matthew Rieke, M.D. | Peter Sears | Geeta Vemuri, Ph.D. Patrick Lee Our Team P. Sherrill Neff Managing Partner Mr. Neff is a founding partner of Quaker BioVentures, a $280 million Mid-Atlantic life sciences venture capital firm...
17.BioAdvance Ventures : Team   (23%):
Ira M. Lubert | Brenda D. Gavin | P. Sherrill Neff | Richard Kollender | Matthew Rieke, M.D. | Peter Sears | Geeta Vemuri, Ph.D. Patrick Lee Our Team Richard Kollender Principal Mr. Kollender joined Quaker BioVentures as a Principal in early 2003. Previously, he worked at GlaxoSmithKline (GSK), wher...
18.BioAdvance   (23%):
About BioAdvance Management Team Board of Directors Fact Sheet Greenhouse Fund Process Eligibility Instructions Login Portfolio Companies BioAdvance Ventures Sponsored Initiatives BioInformatics Clinical Trials Consortium About the Region PA Life Sciences Initiative News Press Releases Articles Medi...
19.BioAdvance Ventures : Team   (22%):
Ira M. Lubert | Brenda D. Gavin | P. Sherrill Neff | Richard Kollender | Matthew Rieke, M.D. | Peter Sears | Geeta Vemuri, Ph.D. Patrick Lee Our Team Ira M. Lubert Managing Partner Mr. Lubert is a founding partner of Quaker BioVentures. He has over 17 years of experience in the venture capital indus...
20.BioAdvance Ventures : Advisory Board   (22%):
Advisory Board BioAdvance Ventures will have access through Quaker BioVentures and through the Biotechnology Greenhouse of Southeastern Pennsylvania to several leading biotech executives and academic advisors. For more on information about our affiliates see ( www.quakerbio.com ) and ( www.bioadvanc...

Page: 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20  

VC Directory: A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   Others